Treating deadly cancerous disorders with gene-guided, targeted therapy
Genomic testing of biopsies from patients with deadly, treatment-resistant cancerous blood syndromes called histiocytoses allowed doctors to identify genes fuelling the ailments and use targeted molecular drugs to successfully treat them. Researchers from the Cincinnati Children’s Cancer and Blood Diseases Institute have recently report their data. They recommend the regular use of comprehensive genomic profiling […]
